Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.
Bennett JM, Young MS, Liesveld JL, Paietta E, Miller KB, Lazarus HM, Marsh RD, Friedenberg WR, Saba HT, Hayes FA, Dewald GW, Hiddemann W, Rowe JM. Bennett JM, et al. Among authors: hayes fa. Am J Hematol. 2001 Jan;66(1):23-7. doi: 10.1002/1096-8652(200101)66:1<23::AID-AJH1002>3.0.CO;2-B. Am J Hematol. 2001. PMID: 11426487 Free article. Clinical Trial.
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.
Rowe JM, Neuberg D, Friedenberg W, Bennett JM, Paietta E, Makary AZ, Liesveld JL, Abboud CN, Dewald G, Hayes FA, Tallman MS, Wiernik PH; Eastern Cooperative Oncology. Rowe JM, et al. Among authors: hayes fa. Blood. 2004 Jan 15;103(2):479-85. doi: 10.1182/blood-2003-05-1686. Epub 2003 Sep 25. Blood. 2004. PMID: 14512295 Free article. Clinical Trial.
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).
Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH. Rowe JM, et al. Among authors: hayes fa. Blood. 1995 Jul 15;86(2):457-62. Blood. 1995. PMID: 7605984 Free article. Clinical Trial.
Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma.
Leong SP, Enders-Zohr P, Zhou YM, Stuntebeck S, Habib FA, Allen RE Jr, Sagebiel RW, Glassberg AB, Lowenberg DW, Hayes FA. Leong SP, et al. Among authors: hayes fa. J Immunother. 1999 Mar;22(2):166-74. doi: 10.1097/00002371-199903000-00008. J Immunother. 1999. PMID: 10093041 Clinical Trial.
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study.
Castleberry RP, Cantor AB, Green AA, Joshi V, Berkow RL, Buchanan GR, Leventhal B, Mahoney DH, Smith EI, Hayes FA. Castleberry RP, et al. Among authors: hayes fa. J Clin Oncol. 1994 Aug;12(8):1616-20. doi: 10.1200/JCO.1994.12.8.1616. J Clin Oncol. 1994. PMID: 8040674 Clinical Trial.
115 results